Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge.

Burns DL, Meade BD, Messionnier NE.

J Infect Dis. 2014 Apr 1;209 Suppl 1:S32-5. doi: 10.1093/infdis/jit491. Review. No abstract available.

PMID:
24626870
2.

Possible options for new pertussis vaccines.

Meade BD, Plotkin SA, Locht C.

J Infect Dis. 2014 Apr 1;209 Suppl 1:S24-7. doi: 10.1093/infdis/jit531. Review.

PMID:
24626868
3.

Use of site-directed mutagenesis to model the effects of spontaneous deamidation on the immunogenicity of Bacillus anthracis protective antigen.

Verma A, McNichol B, Domínguez-Castillo RI, Amador-Molina JC, Arciniega JL, Reiter K, Meade BD, Ngundi MM, Stibitz S, Burns DL.

Infect Immun. 2013 Jan;81(1):278-84. doi: 10.1128/IAI.00863-12. Epub 2012 Oct 31.

4.

Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant.

Wagner L, Verma A, Meade BD, Reiter K, Narum DL, Brady RA, Little SF, Burns DL.

Clin Vaccine Immunol. 2012 Sep;19(9):1465-73. doi: 10.1128/CVI.00174-12. Epub 2012 Jul 18.

5.

Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action.

Ngundi MM, Meade BD, Little SF, Quinn CP, Corbett CR, Brady RA, Burns DL.

Clin Vaccine Immunol. 2012 May;19(5):731-9. doi: 10.1128/CVI.05714-11. Epub 2012 Mar 21.

6.

Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.

Kapasi A, Meade BD, Plikaytis B, Pawloski L, Martin MD, Yoder S, Rock MT, Coddens S, Haezebroeck V, Fievet-Groyne F, Bixler G, Jones C, Hildreth S, Edwards KM, Messonnier NE, Tondella ML.

Clin Vaccine Immunol. 2012 Jan;19(1):64-72. doi: 10.1128/CVI.05460-11. Epub 2011 Nov 23.

7.

Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assays.

Brady RA, Verma A, Meade BD, Burns DL.

Clin Vaccine Immunol. 2010 Sep;17(9):1390-7. doi: 10.1128/CVI.00145-10. Epub 2010 Jul 14.

8.

Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.

Madore DV, Meade BD, Rubin F, Deal C, Lynn F; Meeting Contributors.

Vaccine. 2010 Jun 23;28(29):4539-47. doi: 10.1016/j.vaccine.2010.04.094. Epub 2010 May 12.

9.

Comparison of three anthrax toxin neutralization assays.

Ngundi MM, Meade BD, Lin TL, Tang WJ, Burns DL.

Clin Vaccine Immunol. 2010 Jun;17(6):895-903. doi: 10.1128/CVI.00513-09. Epub 2010 Apr 7.

10.

Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.

Menzies SL, Kadwad V, Pawloski LC, Lin TL, Baughman AL, Martin M, Tondella ML, Meade BD; Pertussis Assay Working Group.

Clin Vaccine Immunol. 2009 Dec;16(12):1781-8. doi: 10.1128/CVI.00248-09. Epub 2009 Oct 28.

11.

Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays.

Verma A, Ngundi MM, Meade BD, De Pascalis R, Elkins KL, Burns DL.

Clin Vaccine Immunol. 2009 Oct;16(10):1405-12. doi: 10.1128/CVI.00194-09. Epub 2009 Aug 5.

12.

Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study.

Xing D, Wirsing von König CH, Newland P, Riffelmann M, Meade BD, Corbel M, Gaines-Das R.

Clin Vaccine Immunol. 2009 Mar;16(3):303-11. doi: 10.1128/CVI.00372-08. Epub 2008 Dec 24.

13.

International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007.

Tondella ML, Carlone GM, Messonnier N, Quinn CP, Meade BD, Burns DL, Cherry JD, Guiso N, Hewlett EL, Edwards KM, Xing D, Giammanco A, Wirsing von König CH, Han L, Hueston L, Robbins JB, Powell M, Mink CM, Poolman JT, Hildreth SW, Lynn F, Morris A.

Vaccine. 2009 Feb 5;27(6):803-14. doi: 10.1016/j.vaccine.2008.11.072. Epub 2008 Dec 9.

PMID:
19071179
14.

Mixture model analysis for establishing a diagnostic cut-off point for pertussis antibody levels.

Baughman AL, Bisgard KM, Lynn F, Meade BD.

Stat Med. 2006 Sep 15;25(17):2994-3010.

PMID:
16345022
15.

Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.

Rosen JB, Breman JG, Manclark CR, Meade BD, Collins WE, Lobel HO, Saliou P, Roberts JM, Campaoré P, Miller MA.

Malar J. 2005 Nov 6;4:53.

16.

Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States.

Baughman AL, Bisgard KM, Edwards KM, Guris D, Decker MD, Holland K, Meade BD, Lynn F.

Clin Diagn Lab Immunol. 2004 Nov;11(6):1045-53.

17.

Use of coefficient of variation in assessing variability of quantitative assays.

Reed GF, Lynn F, Meade BD.

Clin Diagn Lab Immunol. 2002 Nov;9(6):1235-9. Erratum in: Clin Diagn Lab Immunol. 2003 Nov;10(6):1162.

18.

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines.

Rennels MB, Deloria MA, Pichichero ME, Losonsky GA, Englund JA, Meade BD, Anderson EL, Steinhoff MC, Edwards KM.

Pediatrics. 2000 Jan;105(1):e12.

PMID:
10617749
19.

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.

Pichichero ME, Edwards KM, Anderson EL, Rennels MB, Englund JA, Yerg DE, Blackwelder WC, Jansen DL, Meade BD.

Pediatrics. 2000 Jan;105(1):e11.

PMID:
10617748
20.

Evaluation of pertussis in U.S. Marine Corps trainees.

Jansen DL, Gray GC, Putnam SD, Lynn F, Meade BD.

Clin Infect Dis. 1997 Nov;25(5):1099-107.

PMID:
9402365
21.

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.

Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD.

Pediatrics. 1997 Nov;100(5):772-88.

PMID:
9346976
22.
23.

Preparation and standardization of U.S. Standard Pertussis Vaccine, Lot No. 11.

Jansen DL, Meade BD.

Biologicals. 1996 Dec;24(4):363-70. Erratum in: Biologicals 1997 Sep;25(3):363-4.

PMID:
9088553
25.

The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data.

Reed GF, Meade BD, Steinhoff MC.

Pediatrics. 1995 Sep;96(3 Pt 2):600-3.

PMID:
7659485
26.

Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines.

Meade BD, Lynn F, Reed GF, Mink CM, Romani TA, Deforest A, Deloria MA.

Pediatrics. 1995 Sep;96(3 Pt 2):595-600. Erratum in: Pediatrics 1995 Dec;96(6):following 1199.

PMID:
7659484
27.

The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids.

Englund JA, Anderson EL, Reed GF, Decker MD, Edwards KM, Pichichero ME, Steinhoff MC, Rennels MB, Deforest A, Meade BD.

Pediatrics. 1995 Sep;96(3 Pt 2):580-4.

PMID:
7659480
28.

Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines.

Meade BD, Deforest A, Edwards KM, Romani TA, Lynn F, O'Brien CH, Swartz CB, Reed GF, Deloria MA.

Pediatrics. 1995 Sep;96(3 Pt 2):570-5. Erratum in: Pediatrics 1995 Dec;96(6):following 1199.

PMID:
7659478
29.

A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines.

Steinhoff MC, Reed GF, Decker MD, Edwards KM, Englund JA, Pichichero ME, Rennels MB, Anderson EL, Deloria MA, Meade BD.

Pediatrics. 1995 Sep;96(3 Pt 2):567-70.

PMID:
7659477
30.

Comparison of 13 acellular pertussis vaccines: overview and serologic response.

Edwards KM, Meade BD, Decker MD, Reed GF, Rennels MB, Steinhoff MC, Anderson EL, Englund JA, Pichichero ME, Deloria MA.

Pediatrics. 1995 Sep;96(3 Pt 2):548-57.

PMID:
7659475
31.

Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections.

Meade BD, Bollen A.

J Med Microbiol. 1994 Jul;41(1):51-5. No abstract available.

PMID:
7911841
32.
33.

Recent advances in the development of pertussis vaccines.

Brennan MJ, Burns DL, Meade BD, Shahin RD, Manclark CR.

Biotechnology. 1992;20:23-52. Review. No abstract available.

PMID:
1600382
34.

Laboratory correlates of protection and protective immunity to Bordetella pertussis.

Shahin RD, Mink C, Wiedermann BL, Meade BD.

Adv Exp Med Biol. 1992;327:287-92. Review. No abstract available.

PMID:
1295347
35.

A pertussis outbreak in a Wisconsin nursing home.

Addiss DG, Davis JP, Meade BD, Burstyn DG, Meissner M, Zastrow JA, Berg JL, Drinka P, Phillips R.

J Infect Dis. 1991 Oct;164(4):704-10.

PMID:
1894932
36.
37.

Pertussis in a previously immunized child with human immunodeficiency virus infection.

Adamson PC, Wu TC, Meade BD, Rubin M, Manclark CR, Pizzo PA.

J Pediatr. 1989 Oct;115(4):589-92. No abstract available.

PMID:
2795352
38.

Comparison of Tensilon and antivenom for the treatment of cobra-bite paralysis.

Watt G, Meade BD, Theakston RD, Padre LP, Tuazon ML, Calubaquib C, Santiago E, Ranoa CP.

Trans R Soc Trop Med Hyg. 1989 Jul-Aug;83(4):570-3.

PMID:
2694492
39.

Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line.

Backlund PS Jr, Meade BD, Manclark CR, Cantoni GL, Aksamit RR.

Proc Natl Acad Sci U S A. 1985 May;82(9):2637-41.

40.
42.

In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.

Meade BD, Kind PD, Ewell JB, McGrath PP, Manclark CR.

Infect Immun. 1984 Sep;45(3):718-25.

43.

The Sézary syndrome: a malignant proliferation of helper T cells.

Broder S, Edelson RL, Lutzner MA, Nelson DL, MacDermott RP, Durm ME, Goldman CK, Meade BD, Waldmann TA.

J Clin Invest. 1976 Dec;58(6):1297-306.

Supplemental Content

Loading ...
Support Center